prolylglutamic acid has been researched along with phenylalanylglycine in 2 studies
Studies (prolylglutamic acid) | Trials (prolylglutamic acid) | Recent Studies (post-2010) (prolylglutamic acid) | Studies (phenylalanylglycine) | Trials (phenylalanylglycine) | Recent Studies (post-2010) (phenylalanylglycine) |
---|---|---|---|---|---|
10 | 0 | 5 | 32 | 0 | 13 |
Protein | Taxonomy | prolylglutamic acid (IC50) | phenylalanylglycine (IC50) |
---|---|---|---|
Solute carrier family 15 member 1 | Homo sapiens (human) | 0.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faria, TN; Quan, Y; Smith, RL; Stouch, TR; Timoszyk, JK; Vig, BS; Wall, DA | 1 |
Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
2 other study(ies) available for prolylglutamic acid and phenylalanylglycine
Article | Year |
---|---|
Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding.
Topics: Animals; Binding Sites; Biological Transport; Cell Line; Dipeptides; Dogs; Electricity; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Peptide Transporter 1; Proline; Protein Binding; Protein Conformation; Structure-Activity Relationship; Symporters | 2006 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |